Related references
Note: Only part of the references are listed.Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritis
Zsuzsa Jenei-Lanzl et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis
Thais B. Ferreira et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Neurobehavioral aspects, pathophysiology, and management of Tourette syndrome
David R. Shprecher et al.
CURRENT OPINION IN NEUROLOGY (2014)
Reduction of rat brain CD8+ T-cells by levodopa/benserazide treatment after experimental stroke
Enida Kuric et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
Towards Neuroimmunotherapy for Cancer: the Neurotransmitters Glutamate, Dopamine and GnRH-II augment substantially the ability of T cells of few Head and Neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains
Sven Saussez et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Expression of Dopaminergic Receptors on Human CD4+T Lymphocytes: Flow Cytometric Analysis of Naive and Memory Subsets and Relevance for the Neuroimmunology of Neurodegenerative Disease
Natasa Kustrimovic et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2014)
Therapeutic effect of D1-like dopamine receptor antagonist on collagen-induced arthritis of mice
Hiroki Nakashioya et al.
Modern Rheumatology (2014)
The dopaminergic system in autoimmune diseases
Rodrigo Pacheco et al.
FRONTIERS IN IMMUNOLOGY (2014)
Distorted expression of dopamine receptor genes in systemic lupus erythematosus
Mohieddin Jafari et al.
IMMUNOBIOLOGY (2013)
Catecholamine production is differently regulated in splenic T- and B-cells following stress exposure
Marcela Laukova et al.
IMMUNOBIOLOGY (2013)
D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells
Tomoko Mori et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2013)
Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson's Disease
Hugo Gonzalez et al.
JOURNAL OF IMMUNOLOGY (2013)
Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?
Marco Cosentino et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Dopaminergic symptoms in migraine
Piero Barbanti et al.
NEUROLOGICAL SCIENCES (2013)
Modulation of T-cell Mediated Immunity by Dopamine Receptor D5
Carolina Prado et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2013)
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease
Tiziana Alberio et al.
IUBMB LIFE (2012)
Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity
Carolina Prado et al.
JOURNAL OF IMMUNOLOGY (2012)
Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity
Gustavo E. A. Brito-Melo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy
Marco Cosentino et al.
NEUROIMMUNOMODULATION (2012)
Dopamine Induces IL-6-Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model
Kazuhisa Nakano et al.
JOURNAL OF IMMUNOLOGY (2011)
Dopamine D1-Like Receptor Antagonist Attenuates Th17-Mediated Immune Response and Ovalbumin Antigen-Induced Neutrophilic Airway Inflammation
Kazuyuki Nakagome et al.
JOURNAL OF IMMUNOLOGY (2011)
Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder
Thais B. Ferreira et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood
U. Fiszer et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target
Silvia Capellino et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The immunoregulatory role of dopamine: An update
Chandrani Sarkar et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
D1 and D2 Dopamine Receptor-mediated Inhibition of Activated Normal T Cell Proliferation Is Lost in Jurkat T Leukemic Cells
Biswarup Basu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Expression of Apoptosis-related Proteins and of mRNA for Dopaminergic Receptors in Peripheral Blood Mononuclear Cells From Patients With Alzheimer Disease
Marco Cosentino et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Human Immunodeficiency Virus (HIV) Infection of Human Macrophages Is Increased by Dopamine A Bridge between HIV-Associated Neurologic Disorders and Drug Abuse
Peter J. Gaskill et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes
Carina Strell et al.
BMC IMMUNOLOGY (2009)
Calcium Homeostasis Is Dysregulated in Parkinsonian Patients With L-DOPA-Induced Dyskinesias
Fabio Blandini et al.
CLINICAL NEUROPHARMACOLOGY (2009)
Dopamine released by dendritic cells polarizes Th2 differentiation
Kazuhisa Nakano et al.
INTERNATIONAL IMMUNOLOGY (2009)
Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2009)
Role of dopamine in the physiology of T-cells and dendritic cells
Rodrigo Pacheco et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Microglial responses to dopamine in a cell culture model of Parkinson's disease
Diego Mastroeni et al.
NEUROBIOLOGY OF AGING (2009)
Upregulation of Phagocyte-Derived Catecholamines Augments the Acute Inflammatory Response
Michael A. Flierl et al.
PLOS ONE (2009)
Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis
Kazuhisa Nakano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors
Mia Levite
CURRENT OPINION IN PHARMACOLOGY (2008)
Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis
Mauro Zaffaroni et al.
EXPERIMENTAL NEUROLOGY (2008)
Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation
R. H. Straub et al.
GUT (2008)
Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays
Galina P. Kirillova et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients
Marco Ferrari et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Mechanisms of disease: Systemic lupus erythematosus
Anisur Rahman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Eric J. Benner et al.
PLOS ONE (2008)
Phagocyte-derived catecholamines enhance acute inflammatory injury
Michael A. Flierl et al.
NATURE (2007)
MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice
E. Balkowiec-Iskra et al.
INFLAMMATION RESEARCH (2007)
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop
Marco Cosentino et al.
BLOOD (2007)
Cutting edge:: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation
Chandrani Sarkar et al.
JOURNAL OF IMMUNOLOGY (2006)
Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment
F. Magro et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+-T cells
EM Boneberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Psychopathology in children and adolescents with Tourette's syndrome: A controlled study
C Termine et al.
BRAIN & DEVELOPMENT (2006)
Recent advances in Tourette syndrome research
RL Albin et al.
TRENDS IN NEUROSCIENCES (2006)
Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3
Y Watanabe et al.
JOURNAL OF IMMUNOLOGY (2006)
Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice
KK Anderson et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both
MJ Besser et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
CF Orr et al.
BRAIN (2005)
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients:: Effects of IFN-β
M Giorelli et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Dopamine and noradrenaline control distinct functions in rodent microglial cells
K Färber et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2005)
Increased dopamine content in lymphocytes from high-dose L-Dopa-treated Parkinson's disease patients
C Rajda et al.
NEUROIMMUNOMODULATION (2005)
Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum
K Minzer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-γ upon L-DOPA uptake
F Magro et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2004)
Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes
M Ferrari et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity:: Implications for neurodegeneration
J Kipnis et al.
JOURNAL OF NEUROSCIENCE (2004)
Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice
DA Ballok et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: Evidence for a D1-like receptor-dependent protective effect
M Cosentino et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells
MC Ghosh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration
Y Ganor et al.
JOURNAL OF IMMUNOLOGY (2003)
In vivo administration of L-dopa or dopamine decreases the number of splenic IFN-γ-producing cells
L Carr et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis
M Cosentino et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study
F McKenna et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression
P Rocca et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
The behavioral spectrum of tic disorders - A community-based study
R Kurlan et al.
NEUROLOGY (2002)
Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET
HS Singer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence
B Sakic et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Stimulation with phytohaemagglutinin induces the synthesis of catecholamines in human peripheral blood mononuclear cells: role of protein kinase C and contribution of intracellular calcium
M Cosentino et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease
K Hisanaga et al.
ARCHIVES OF NEUROLOGY (2001)
Bromocriptine in rheumatic and autoimmune diseases
RW McMurray
SEMINARS IN ARTHRITIS AND RHEUMATISM (2001)
Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+and CD8+T cells by D1 dopamine receptors: an in vitro analysis
B Saha et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
J Bas et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Risperidone versus pimozide in Tourette's disorder: A comparative double-blind parallel-group study
R Bruggeman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+and CD8+T cells in vitro: A receptor-mediated mechanism
B Saha et al.
NEUROIMMUNOMODULATION (2001)
Does Parkinson's disease have an immunological basis? The evidence and its therapeutic implications
U Fiszer
BIODRUGS (2001)
Bromocriptine restores tolerance in estrogen-treated mice
E Peeva et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease
P Barbanti et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2000)
Dopamine, a neurotransmitter, influences the immune system
S Basu et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels
PB Fitzgerald et al.
PSYCHOPHARMACOLOGY (2000)
Share Paper
